Tilak Healthcare, a Paris, France-based ophthalmological digital health company, raised €10M in funding.
The round, which brought the total amount to €22M, was led by Elaia and Cap Hornet with participation from iBionext and SWEN Capital Partners, along with Théa, Adelie and angels including Yann Fleureau.
The company intends to use the funds to accelerate product rollout in France and abroad, alongside developing a diverse product range around OdySight.
Led by CEO Edouard Gasser, Tilak Healthcare is a digital healthcare provider that is developing a technology platform involving medical video games prescribed by healthcare professionals to help people with chronic vision disorders. OdySight, its platform, focuses on ophthalmology and in particular chronic macular degeneration. It is already used in the United States and Europe, particularly as a result of a co-promotion partnership in France with Laboratoires Théa.
FinSMEs
12/10/2023